Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Facial Paralysis | 6 | 2022 | 25 | 3.780 |
Why?
|
| Rhinoplasty | 3 | 2022 | 27 | 2.430 |
Why?
|
| Nerve Transfer | 3 | 2022 | 5 | 1.650 |
Why?
|
| Thyroid Neoplasms | 3 | 2014 | 68 | 1.270 |
Why?
|
| Adenocarcinoma, Follicular | 2 | 2014 | 13 | 0.940 |
Why?
|
| Masseter Muscle | 3 | 2022 | 6 | 0.900 |
Why?
|
| Surgical Flaps | 2 | 2021 | 120 | 0.850 |
Why?
|
| Carcinoma | 2 | 2014 | 215 | 0.830 |
Why?
|
| Rhinitis | 4 | 2014 | 383 | 0.800 |
Why?
|
| Nasal Obstruction | 1 | 2021 | 34 | 0.790 |
Why?
|
| Sinusitis | 4 | 2014 | 432 | 0.770 |
Why?
|
| Nasal Surgical Procedures | 1 | 2021 | 21 | 0.770 |
Why?
|
| Skin Transplantation | 1 | 2021 | 45 | 0.770 |
Why?
|
| Fascia Lata | 1 | 2020 | 2 | 0.760 |
Why?
|
| Nose Deformities, Acquired | 1 | 2020 | 6 | 0.760 |
Why?
|
| Lichen Planus | 1 | 2020 | 17 | 0.730 |
Why?
|
| Hair | 1 | 2020 | 46 | 0.720 |
Why?
|
| Alopecia | 1 | 2020 | 45 | 0.700 |
Why?
|
| Gracilis Muscle | 1 | 2018 | 1 | 0.690 |
Why?
|
| Tendon Transfer | 1 | 2018 | 7 | 0.680 |
Why?
|
| Mandibular Nerve | 1 | 2018 | 4 | 0.650 |
Why?
|
| Skull Neoplasms | 2 | 2019 | 23 | 0.600 |
Why?
|
| Nasal Polyps | 3 | 2014 | 184 | 0.590 |
Why?
|
| Facial Nerve | 3 | 2022 | 25 | 0.510 |
Why?
|
| Paranasal Sinuses | 2 | 2013 | 165 | 0.510 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 45 | 0.470 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 52 | 0.470 |
Why?
|
| Nasal Mucosa | 1 | 2013 | 68 | 0.450 |
Why?
|
| Osteoma | 1 | 2012 | 6 | 0.430 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2012 | 2 | 0.430 |
Why?
|
| Humans | 26 | 2022 | 68525 | 0.430 |
Why?
|
| Cytokines | 2 | 2013 | 866 | 0.420 |
Why?
|
| Smiling | 2 | 2022 | 7 | 0.380 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 2019 | 13 | 0.340 |
Why?
|
| Facial Nerve Diseases | 2 | 2019 | 13 | 0.340 |
Why?
|
| Endoscopy | 1 | 2012 | 464 | 0.330 |
Why?
|
| Fibroblasts | 1 | 2013 | 902 | 0.330 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 1851 | 0.320 |
Why?
|
| Retrospective Studies | 7 | 2022 | 7264 | 0.310 |
Why?
|
| Forehead | 2 | 2021 | 13 | 0.310 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 318 | 0.290 |
Why?
|
| Cleft Lip | 2 | 2018 | 33 | 0.280 |
Why?
|
| Survival Rate | 3 | 2014 | 1055 | 0.280 |
Why?
|
| Male | 14 | 2021 | 37281 | 0.270 |
Why?
|
| Nose | 2 | 2021 | 36 | 0.240 |
Why?
|
| Carcinoma, Papillary | 2 | 2014 | 35 | 0.230 |
Why?
|
| Middle Aged | 8 | 2019 | 21119 | 0.230 |
Why?
|
| Adult | 7 | 2022 | 21375 | 0.230 |
Why?
|
| Female | 12 | 2018 | 38015 | 0.230 |
Why?
|
| Antifungal Agents | 2 | 2014 | 108 | 0.220 |
Why?
|
| Treatment Outcome | 7 | 2018 | 7028 | 0.210 |
Why?
|
| Nasal Septum | 1 | 2021 | 16 | 0.210 |
Why?
|
| Sutures | 1 | 2021 | 32 | 0.200 |
Why?
|
| Cicatrix | 1 | 2021 | 60 | 0.200 |
Why?
|
| Recovery of Function | 3 | 2020 | 506 | 0.200 |
Why?
|
| Printing, Three-Dimensional | 1 | 2021 | 31 | 0.190 |
Why?
|
| Nose Neoplasms | 1 | 2021 | 25 | 0.190 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2021 | 40 | 0.190 |
Why?
|
| Botulinum Toxins | 1 | 2020 | 18 | 0.190 |
Why?
|
| Aged | 5 | 2021 | 14842 | 0.190 |
Why?
|
| Health Literacy | 1 | 2020 | 62 | 0.180 |
Why?
|
| Dermoscopy | 1 | 2020 | 14 | 0.180 |
Why?
|
| Chronic Disease | 3 | 2013 | 1329 | 0.180 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 145 | 0.180 |
Why?
|
| Scalp | 1 | 2020 | 47 | 0.180 |
Why?
|
| Sex Factors | 2 | 2014 | 1265 | 0.180 |
Why?
|
| Infant | 3 | 2022 | 2891 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2019 | 7 | 0.170 |
Why?
|
| Mastoid | 1 | 2019 | 20 | 0.170 |
Why?
|
| Carcinoma, Ductal | 1 | 2018 | 14 | 0.170 |
Why?
|
| Facial Asymmetry | 1 | 2018 | 5 | 0.160 |
Why?
|
| Esthetics | 1 | 2018 | 18 | 0.160 |
Why?
|
| Parotid Neoplasms | 1 | 2018 | 49 | 0.160 |
Why?
|
| Age Factors | 2 | 2014 | 1860 | 0.160 |
Why?
|
| Prognosis | 2 | 2014 | 2093 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 375 | 0.140 |
Why?
|
| Neuroma, Acoustic | 1 | 2016 | 17 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2021 | 3702 | 0.140 |
Why?
|
| Adolescent | 3 | 2013 | 8903 | 0.130 |
Why?
|
| Lip | 1 | 2014 | 12 | 0.130 |
Why?
|
| Child | 3 | 2022 | 6400 | 0.130 |
Why?
|
| Velopharyngeal Sphincter | 1 | 2014 | 7 | 0.120 |
Why?
|
| Adenoids | 1 | 2014 | 15 | 0.120 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2014 | 14 | 0.120 |
Why?
|
| SEER Program | 1 | 2014 | 150 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 4843 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 186 | 0.110 |
Why?
|
| Cell Communication | 1 | 2013 | 116 | 0.110 |
Why?
|
| Olfaction Disorders | 1 | 2014 | 100 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 799 | 0.100 |
Why?
|
| Biopsy | 1 | 2013 | 539 | 0.100 |
Why?
|
| Young Adult | 2 | 2013 | 5708 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 498 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 438 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 1026 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2673 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2016 | 1615 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2014 | 2356 | 0.080 |
Why?
|
| Biomarkers | 1 | 2013 | 1593 | 0.080 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2006 | 6 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2006 | 62 | 0.070 |
Why?
|
| Anxiety | 1 | 2009 | 422 | 0.070 |
Why?
|
| Estradiol | 1 | 2006 | 176 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1465 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2006 | 192 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2077 | 0.060 |
Why?
|
| Risk Factors | 1 | 2013 | 5719 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 756 | 0.050 |
Why?
|
| Depression | 1 | 2009 | 942 | 0.050 |
Why?
|
| United States | 1 | 2014 | 7335 | 0.050 |
Why?
|
| Reading | 1 | 2020 | 19 | 0.050 |
Why?
|
| Authorship | 1 | 2020 | 18 | 0.050 |
Why?
|
| Comprehension | 1 | 2020 | 71 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 2222 | 0.040 |
Why?
|
| Parotid Gland | 1 | 2018 | 33 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3256 | 0.040 |
Why?
|
| Neck Dissection | 1 | 2018 | 55 | 0.040 |
Why?
|
| Photography | 1 | 2018 | 37 | 0.040 |
Why?
|
| Internet | 1 | 2020 | 390 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1533 | 0.040 |
Why?
|
| Hypoglossal Nerve | 1 | 2016 | 5 | 0.040 |
Why?
|
| Software | 1 | 2018 | 418 | 0.030 |
Why?
|
| Drug Administration Routes | 1 | 2014 | 25 | 0.030 |
Why?
|
| Rotation | 1 | 2014 | 58 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2014 | 53 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 91 | 0.030 |
Why?
|
| Diuretics | 1 | 2014 | 96 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 89 | 0.030 |
Why?
|
| Adenoidectomy | 1 | 2014 | 51 | 0.030 |
Why?
|
| Antibodies | 1 | 2014 | 241 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 242 | 0.030 |
Why?
|
| Smell | 1 | 2014 | 131 | 0.030 |
Why?
|
| Reoperation | 1 | 2014 | 467 | 0.030 |
Why?
|
| South Carolina | 1 | 2018 | 2750 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3185 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 929 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 4655 | 0.020 |
Why?
|
| Culture Media | 1 | 2006 | 155 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 2798 | 0.020 |
Why?
|
| Cell Division | 1 | 2006 | 541 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 320 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2006 | 332 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 1849 | 0.010 |
Why?
|